Key Findings From Recent Trials

Basic Phenergan Information

• INN (International Nonproprietary Name): Promethazine hydrochloride
• Brand Names Available In United States: not specified
• ATC Code: R06AD02
• Forms & Dosages: Tablets 10 mg and 25 mg; Elixir 1 mg/mL (100 mL bottle); Suppositories 12.5 mg, 25 mg, 50 mg (suppositories are less commonly available or discontinued by some suppliers)
• Manufacturers In United States: not specified
• Registration Status In United States: not specified
• OTC / Rx Classification: Prescription medication (Rx) in most countries (e.g., UK, AU)

Major 2022–2026 Studies

What does modern research tell us about Phenergan and promethazine safety?

Recent randomized controlled trials directly naming Phenergan are limited between 2022 and 2026.

Most of the recent evidence comes from pharmacovigilance analyses, tolerability reviews, and comparative safety reviews of first‑generation antihistamines.

These reviews use data from postmarketing reports and national safety advisories rather than fresh large RCTs.

Main Outcomes

Which outcomes keep clinicians advising caution?

Promethazine remains effective for short‑term control of nausea, motion sickness, and as a sedative for preoperative use.

Comparative syntheses rank promethazine high for symptomatic efficacy but note a greater sedative and anticholinergic burden than second‑generation antihistamines.

Controlled studies for chronic indications are sparse, so long‑term benefit data are limited.

Safety Observations

What safety signals appeared in recent surveillance?

Major regulatory incident reports since 2022 emphasize serious respiratory depression risk in very young children and accumulation risks in hepatic impairment.

Postmarketing surveillance continues to show increased falls and confusion in elderly patients, paradoxical excitation in some pediatric reports, and CNS/anticholinergic clusters in overdoses.

These findings align with existing product labeling and TGA/MHRA advisories cited in international registrations.

Clinical Mechanism Of Action

Layman’s Explanation

How does promethazine help with nausea and allergies?

Promethazine is a first‑generation antihistamine that blocks H1 histamine receptors to reduce allergy symptoms.

It also blocks other receptors in the brain to relieve nausea and cause sedation.

Scientific Breakdown

What does promethazine do at a molecular level?

Promethazine is a phenothiazine derivative with strong H1 antagonism and significant anticholinergic, sedative, and antiemetic properties.

Its central H1 blockade explains both sedation and antiemetic efficacy.

Anticholinergic activity explains dry mouth, blurred vision, and constipation.

It has modest dopamine D2 affinity compared with antipsychotic phenothiazines, which may explain rare extrapyramidal reactions.

Receptor Profile

Which receptors does promethazine bind?

Strong H1 antagonism is the primary action responsible for symptomatic relief of allergic reactions and sedation.

Moderate muscarinic antagonism accounts for anticholinergic adverse effects.

Minimal alpha‑adrenergic and D2 activity exist but are not central to routine clinical use.

CNS Effects

How does promethazine affect the brain and behavior?

Promethazine crosses the blood–brain barrier readily and causes sedation and drowsiness.

Hepatic metabolism can extend its half‑life in patients with liver impairment, so dose adjustments are often recommended in labeling.

Scope Of Approved And Off‑Label Use

United States Approvals

What are the standard approved uses worldwide that clinicians rely on?

Promethazine is routinely indicated for symptomatic relief of allergic conditions, prevention of motion sickness, and as an antiemetic and sedative in preoperative settings.

Product registrations cited in several countries classify promethazine as prescription‑only, and clinicians in the United States refer to national labeling for allergy and nausea indications.

Notable Off‑Label Trends

How do prescribers use promethazine beyond labeled indications?

Clinicians commonly use promethazine off‑label for migraine‑associated nausea and as adjunctive sedation in palliative care.

It is sometimes used for postoperative nausea when guideline agents are not suitable or available.

Use in very young children and the elderly has declined because of safety advisories prohibiting use in children under 2 years and recommending caution in older adults.

Dosage Strategy

General Dosing

What doses are available and how are they typically used?

Tablets are commonly available in 10 mg and 25 mg strengths and elixir is 1 mg/mL in 100 mL bottles.

Typical adult dosing per product information is 10–25 mg at night or 10 mg two to three times daily for allergy relief.

For preoperative sedation or acute nausea, adult doses of 25–50 mg are cited in product information.

Pediatric dosing is age‑ and weight‑based and promethazine is contraindicated under 2 years because of fatal respiratory depression risk.

Condition‑Specific Dosing

How do doses change by condition?

For motion sickness, a single pre‑exposure dose is common — 25 mg for adults and 12.5–25 mg for older children.

For nausea and vomiting, 25–50 mg may be given and can be repeated every 4–6 hours as needed with monitoring for anticholinergic effects.

For sedation or short‑term insomnia, dosing should be limited to short courses due to cognitive effects and risk of dependency.

Adjust doses downward in elderly patients and in hepatic or renal impairment.

Safety Protocols

Contraindications

Who should never receive promethazine?

Absolute contraindications include hypersensitivity to promethazine or phenothiazine derivatives and children under 2 years because of the risk of fatal respiratory depression.

Comatose patients or those with severe CNS or respiratory depression should not receive promethazine.

Use with close monitoring in elderly patients, those with severe hepatic or renal impairment, seizure disorders, narrow‑angle glaucoma, prostatic hypertrophy, and significant cardiovascular disease.

Adverse Effects

What side effects should patients expect and how serious can they be?

The most common adverse effects are sedation and drowsiness.

Other frequent effects include dizziness, dry mouth, blurred vision, constipation, headache, and mild hypotension.

Serious risks noted in product labeling and surveillance include respiratory depression in infants and young children, increased falls and confusion in older adults, anticholinergic toxicity, and life‑threatening overdose when misused.

Overdose management centers on emergency care for CNS depression and anticholinergic signs.

Interaction Mapping

Food Interactions

Are there foods to avoid while taking promethazine?

No major food restrictions are listed in product information.

Alcohol and other CNS depressants markedly potentiate promethazine’s sedative and respiratory‑depressant effects, and patients should avoid alcohol while taking promethazine.

Drug Combinations To Avoid

Which drugs increase danger when combined with promethazine?

Strong CNS depressants such as opioids and benzodiazepines raise the risk of excessive sedation and respiratory depression.

Concomitant anticholinergic drugs increase dry mouth, urinary retention, and cognitive impairment.

Drugs that prolong QT or have additive phenothiazine effects require caution because of rare extrapyramidal or cardiac events.

Hepatic enzyme inhibitors or inducers may alter promethazine levels and dose reductions are advised in hepatic impairment.

Always review over‑the‑counter sleep aids and motion‑sickness patches before dispensing.

Patient Experience Analysis

Survey Data

How do patients rate promethazine in real life?

Survey data for first‑generation antihistamines show strong efficacy for acute symptom relief such as nausea, motion sickness, and itching.

Patient satisfaction can be lower for daytime functioning because sedation often interferes with work or driving.

Formulation preferences vary; elixir is often chosen for pediatric dosing and for patients with dysphagia.

Forum Trends

What do online communities say about Phenergan?

Travel and parenting forums commonly recommend Phenergan for motion sickness and peri‑travel nausea, but many threads warn about pediatric risks and paradoxical hyperactivity in some children.

Elderly users frequently report daytime somnolence and dizziness that lead to discontinuation.

These real‑world narratives match product labeling and regulatory cautions and should inform shared decision‑making with patients.

Distribution And Pricing Landscape

How is promethazine supplied and what affects price?

Promethazine is distributed globally under brand names like Phenergan, Avomine, Lergigan, and others and is produced by national manufacturers.

Common packaging includes tablets in blister packs and 100 mL elixir bottles; suppositories are less commonly available or discontinued in some markets.

As a long‑established generic, pricing varies by brand, formulation, and region.

Where prescription status is enforced, pharmacies stock promethazine by prescription only and stock patterns favor tablets and elixir for travel and acute kits.

Alternative Options

Comparison Table

Which drugs offer similar effects with different tradeoffs?

• Diphenhydramine (Benadryl): Similar sedation and anticholinergic effects; commonly used for short‑term allergy or motion sickness relief.
• Chlorpheniramine: First‑generation antihistamine that may be less sedating but still carries anticholinergic risks.
• Cetirizine, Loratadine: Second‑generation antihistamines with minimal sedation better suited for daytime allergy control.
• Ondansetron, Metoclopramide: Non‑anticholinergic antiemetics preferred for severe chemotherapy or postoperative nausea in many guidelines.

Pros And Cons

How do you choose promethazine versus alternatives?

Promethazine pros include effective antiemetic action, inexpensive generics, and multiple formulations such as elixir and tablets.

Cons include a high sedation and anticholinergic burden, contraindication in children under 2, and caution in the elderly and those with hepatic impairment.

When daytime alertness matters, second‑generation antihistamines are usually better for allergic indications.

When severe nausea is present and anticholinergic effects are a concern, consider guideline‑preferred antiemetics instead of promethazine.

Regulatory Status

What do regulators say and where is promethazine listed?

Promethazine is registered and regulated as a prescription medication in many countries and appears on national formularies and registries with ATC classification R06AD02.

Registrations in Australia include TGA AUST R numbers for tablets and elixir and product information includes pediatric warnings and dose adjustments for hepatic impairment.

Regulatory advisories consistently restrict use in children under 2 and recommend caution in elderly and hepatic impairment.

Clinicians in the United States should reference FDA labeling and local formularies for country‑specific guidance.

For some European markets, public registrations and details can be confirmed on the ANMDMR portal.

Consolidated FAQ

Common Patient Questions

Is Phenergan safe for children?

Not under 2 years — promethazine is contraindicated in that age group due to fatal respiratory depression risk.

Older children require weight‑based dosing and close supervision by a physician.

Can I drink alcohol while taking promethazine?

No — alcohol amplifies sedation and respiratory risk and should be avoided.

Is Phenergan over the counter?

Promethazine is generally prescription‑only in many countries, though availability varies by market.

Clinician Troubleshooting

How do prescribers manage common problems with promethazine?

For daytime sedation, try lowering the dose, shifting to nocturnal dosing, or switching to a second‑generation antihistamine for allergy.

If anticholinergic effects are unacceptable in a patient with nausea, consider ondansetron or metoclopramide as alternatives.

In hepatic impairment, reduce dose and increase monitoring because the half‑life may be prolonged.

For suspected overdose presenting with CNS depression or anticholinergic signs, arrange emergency care and supportive treatment following local protocols.

Visual Guide

Suggested Diagrams

Which simple visuals help understanding?

A receptor effect map that links H1 blockade to sedation and antiemetic effect and muscarinic blockade to anticholinergic symptoms is useful.

A dosing flowchart by indication and age group (adult, child ≥2, elderly/with hepatic impairment) clarifies safe selection.

An interaction matrix highlighting high‑risk drug classes such as opioids, benzodiazepines, and anticholinergics helps screen patients quickly.

Patient Handout Elements

What should a one‑page handout contain?

Clear pediatric warning that promethazine is contraindicated under 2 years and instructions to avoid alcohol and other CNS depressants.

A bulleted list of common side effects: sedation, dry mouth, dizziness, blurred vision, and constipation.

Storage advice: keep elixir tightly sealed, store below 30°C (86°F), and keep out of reach of children.

Emergency signs for which to seek urgent care include severe drowsiness and breathing difficulty.

Storage And Transport

How should pharmacies and patients store promethazine?

Label guidance is to store below 30°C (86°F), protect from direct light, and keep in original packaging.

Elixir bottles should be tightly sealed and kept out of reach of children.

Transport under standard pharmaceutical conditions avoiding sustained high temperatures or freezing is appropriate.

Verify supplier stock for suppositories as some formulations may be discontinued in certain markets.

Guidelines For Proper Use

Prescriber Checklist

What steps reduce risk when prescribing promethazine?

Confirm the indication and consider alternatives when appropriate, especially for allergy and chronic symptoms.

Verify patient age and avoid giving promethazine to children under 2 years.

Review hepatic and renal function and the full medication list for CNS depressants and anticholinergics.

Choose the appropriate formulation and document counseling on sedation risks and alternatives.

Patient Counseling Points

What should pharmacists tell patients at pickup or delivery?

Explain the purpose of promethazine for allergy, nausea, motion sickness, or sedation and the expected onset and duration of sedation.

Advise against alcohol and other sedative substances while taking promethazine.

Review storage instructions, how to handle a missed dose, and the need for urgent care with signs of overdose.

Provide written instructions and align the treatment plan with patient goals such as maintaining daytime alertness versus nighttime symptom control.

Delivery Across United States

How To Order And Access

Can patients get Phenergan online and how quickly will it arrive?

In our online pharmacy, phenergan is available without a prescription, with discreet delivery to United States in 5-14 days.

Products are commonly sold as tablets and elixir and shipping times depend on city and stock availability.

Practical Examples And Counseling Scenarios

What might a typical counseling moment sound like at the pharmacy?

A traveler asks for something for severe motion sickness and prefers a liquid for a child over 6 years.

The pharmacist confirms age and weight, explains the 12.5–25 mg single dose for older children, and warns about sedation and not to combine with alcohol.

An older patient picking up promethazine for postoperative nausea is counseled to avoid driving the same day and to review all other sedating medications.

These short, concrete examples match product information and safety advisories and help practical decision‑making at the counter.

Quick Reference Summary

What are the bottom‑line points clinicians and patients should remember?

Promethazine (Phenergan) is effective for short‑term nausea, motion sickness, and preoperative sedation but causes marked sedation and anticholinergic effects.

Avoid use in children under 2 and use caution in the elderly and those with hepatic impairment.

Check for dangerous drug combinations, especially opioids and benzodiazepines, and counsel patients to avoid alcohol.

Further Resources

Where can clinicians verify registration and country‑specific advisory details?

Registration and public safety information for some markets can be confirmed at the ANMDMR portal.